• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
CRSwNP Interactive Patient Case Tool
Rhinology
15 min
interactivity

CRSwNP Interactive Patient Case Tool

Beyond Age: Unraveling the Mortality Risk in Bullous Pemphigoid
Dermatology
4 min
expert video

Beyond Age: Unraveling the Mortality Risk in Bullous Pemphigoid

Beneath the Surface: How Autoimmunity and Predominantly Type 2 Inflammation Mediate BP
Dermatology
10 min
expert video

Beneath the Surface: How Autoimmunity and Predominantly Type 2 Inflammation Mediate BP

Recognizing BP and Understanding Its Toll
Dermatology
10 min
expert video

Recognizing BP and Understanding Its Toll

Heterogeneous Presentation and Diagnosis in Bullous Pemphigoid
Dermatology
4 min
expert video

Heterogeneous Presentation and Diagnosis in Bullous Pemphigoid

Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg
Dermatology
10 min
expert video

Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg

Understanding Barriers to Advanced Systemic Therapy in AD
Dermatology
5 min
expert video

Understanding Barriers to Advanced Systemic Therapy in AD

Potential Biomarkers of Subclinical Control in AD Pathophysiology
Dermatology
5 min
expert video

Potential Biomarkers of Subclinical Control in AD Pathophysiology

Clinical Utility of Biomarkers in the Management of AD
Dermatology
5 min
expert video

Clinical Utility of Biomarkers in the Management of AD

Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis
Dermatology
10 min
expert video

Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis

Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
Dermatology
10 min
expert video

Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
Dermatology
10 min
expert video

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU

    1
    ...
    789
    ...
    23